A citation-based method for searching scientific literature

Bjoern Chapuy, Margaretha G M Roemer, Chip Stewart, Yuxiang Tan, Ryan P Abo, Liye Zhang, Andrew J Dunford, David M Meredith, Aaron R Thorner, Ekaterina S Jordanova, Gang Liu, Friedrich Feuerhake, Matthew D Ducar, Gerald Illerhaus, Daniel Gusenleitner, Erica A Linden, Heather H Sun, Heather Homer, Miyuki Aono, Geraldine S Pinkus, Azra H Ligon, Keith L Ligon, Judith A Ferry, Gordon J Freeman, Paul van Hummelen, Todd R Golub, Gad Getz, Scott J Rodig, Daphne de Jong, Stefano Monti, Margaret A Shipp. Blood 2016
Times Cited: 294







List of co-cited articles
1059 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma.
Lakshmi Nayak, Fabio M Iwamoto, Ann LaCasce, Srinivasan Mukundan, Margaretha G M Roemer, Bjoern Chapuy, Philippe Armand, Scott J Rodig, Margaret A Shipp. Blood 2017
243
37

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Bjoern Chapuy, Chip Stewart, Andrew J Dunford, Jaegil Kim, Atanas Kamburov, Robert A Redd, Mike S Lawrence, Margaretha G M Roemer, Amy J Li, Marita Ziepert,[...]. Nat Med 2018
706
31

Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.
Christian Grommes, Alessandro Pastore, Nicolaos Palaskas, Sarah S Tang, Carl Campos, Derrek Schartz, Paolo Codega, Donna Nichol, Owen Clark, Wan-Ying Hsieh,[...]. Cancer Discov 2017
198
28

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma.
Michail S Lionakis, Kieron Dunleavy, Mark Roschewski, Brigitte C Widemann, John A Butman, Roland Schmitz, Yandan Yang, Diane E Cole, Christopher Melani, Christine S Higham,[...]. Cancer Cell 2017
277
27

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Roland Schmitz, George W Wright, Da Wei Huang, Calvin A Johnson, James D Phelan, James Q Wang, Sandrine Roulland, Monica Kasbekar, Ryan M Young, Arthur L Shaffer,[...]. N Engl J Med 2018
826
26

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
Christine P Hans, Dennis D Weisenburger, Timothy C Greiner, Randy D Gascoyne, Jan Delabie, German Ott, H Konrad Müller-Hermelink, Elias Campo, Rita M Braziel, Elaine S Jaffe,[...]. Blood 2004
23

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.
Wyndham H Wilson, Ryan M Young, Roland Schmitz, Yandan Yang, Stefania Pittaluga, George Wright, Chih-Jian Lih, P Mickey Williams, Arthur L Shaffer, John Gerecitano,[...]. Nat Med 2015
700
22

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.
Stephen M Ansell, Alexander M Lesokhin, Ivan Borrello, Ahmad Halwani, Emma C Scott, Martin Gutierrez, Stephen J Schuster, Michael M Millenson, Deepika Cattry, Gordon J Freeman,[...]. N Engl J Med 2015
22

Oncogenically active MYD88 mutations in human lymphoma.
Vu N Ngo, Ryan M Young, Roland Schmitz, Sameer Jhavar, Wenming Xiao, Kian-Huat Lim, Holger Kohlhammer, Weihong Xu, Yandan Yang, Hong Zhao,[...]. Nature 2011
21

Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.
Esteban Braggio, Scott Van Wier, Juhi Ojha, Ellen McPhail, Yan W Asmann, Jan Egan, Jackline Ayres da Silva, David Schiff, M Beatriz Lopes, Paul A Decker,[...]. Clin Cancer Res 2015
120
20

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Steven H Swerdlow, Elias Campo, Stefano A Pileri, Nancy Lee Harris, Harald Stein, Reiner Siebert, Ranjana Advani, Michele Ghielmini, Gilles A Salles, Andrew D Zelenetz,[...]. Blood 2016
20


Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Anupama Reddy, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt, Cassandra L Love, Alexander Waldrop, Sirpa Leppa, Annika Pasanen, Leo Meriranta, Marja-Liisa Karjalainen-Lindsberg,[...]. Cell 2017
536
19

Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas.
T Nakamura, K Tateishi, T Niwa, Y Matsushita, K Tamura, M Kinoshita, K Tanaka, S Fukushima, H Takami, H Arita,[...]. Neuropathol Appl Neurobiol 2016
109
18

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
A A Alizadeh, M B Eisen, R E Davis, C Ma, I S Lossos, A Rosenwald, J C Boldrick, H Sabet, T Tran, X Yu,[...]. Nature 2000
17

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome.
Margaretha G M Roemer, Ranjana H Advani, Azra H Ligon, Yasodha Natkunam, Robert A Redd, Heather Homer, Courtney F Connelly, Heather H Sun, Sarah E Daadi, Gordon J Freeman,[...]. J Clin Oncol 2016
474
17

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Michael R Green, Stefano Monti, Scott J Rodig, Przemyslaw Juszczynski, Treeve Currie, Evan O'Donnell, Bjoern Chapuy, Kunihiko Takeyama, Donna Neuberg, Todd R Golub,[...]. Blood 2010
835
17

Genomic characterization of primary central nervous system lymphoma.
Kazutaka Fukumura, Masahito Kawazu, Shinya Kojima, Toshihide Ueno, Eirin Sai, Manabu Soda, Hiroki Ueda, Takahiko Yasuda, Hiroyuki Yamaguchi, Jeunghun Lee,[...]. Acta Neuropathol 2016
89
19

Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study.
Stephen M Ansell, Monique C Minnema, Peter Johnson, John M Timmerman, Philippe Armand, Margaret A Shipp, Scott J Rodig, Azra H Ligon, Margaretha G M Roemer, Nishitha Reddy,[...]. J Clin Oncol 2019
175
16

Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma.
James L Rubenstein, Huimin Geng, Eleanor J Fraser, Paul Formaker, Lingjing Chen, Jigyasa Sharma, Phoebe Killea, Kaylee Choi, Jenny Ventura, John Kurhanewicz,[...]. Blood Adv 2018
76
21

Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas.
Konstantinos Georgiou, Longyun Chen, Mattias Berglund, Weicheng Ren, Noel F C C de Miranda, Susana Lisboa, Marco Fangazio, Shida Zhu, Yong Hou, Kui Wu,[...]. Blood 2016
129
15

Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma.
Christian Grommes, Sarah S Tang, Julia Wolfe, Thomas J Kaley, Mariza Daras, Elena I Pentsova, Anna F Piotrowski, Jacqueline Stone, Andrew Lin, Craig P Nolan,[...]. Blood 2019
99
15

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, Maurilio Ponzoni, Martina Deckert, Letterio S Politi, Valter Torri, Christopher P Fox, Paul La Rosée, Elisabeth Schorb,[...]. Lancet Haematol 2016
284
14

Primary CNS Lymphoma.
Christian Grommes, Lisa M DeAngelis. J Clin Oncol 2017
235
14

MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas.
Naema Nayyar, Michael D White, Corey M Gill, Matthew Lastrapes, Mia Bertalan, Alexander Kaplan, Megan R D'Andrea, Ivanna Bihun, Andrew Kaneb, Jorg Dietrich,[...]. Blood Adv 2019
40
35

Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma.
David D W Twa, Fong Chun Chan, Susana Ben-Neriah, Bruce W Woolcock, Anja Mottok, King L Tan, Graham W Slack, Jay Gunawardana, Raymond S Lim, Andrew W McPherson,[...]. Blood 2014
205
14


Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.
R Eric Davis, Vu N Ngo, Georg Lenz, Pavel Tolar, Ryan M Young, Paul B Romesser, Holger Kohlhammer, Laurence Lamy, Hong Zhao, Yandan Yang,[...]. Nature 2010
13

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.
Ryan D Morin, Maria Mendez-Lago, Andrew J Mungall, Rodrigo Goya, Karen L Mungall, Richard D Corbett, Nathalie A Johnson, Tesa M Severson, Readman Chiu, Matthew Field,[...]. Nature 2011
13

Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma.
Agnieszka Korfel, Uwe Schlegel, Ulrich Herrlinger, Martin Dreyling, Christian Schmidt, Luisa von Baumgarten, Antonio Pezzutto, Thomas Grobosch, Sied Kebir, Eckhard Thiel,[...]. J Clin Oncol 2016
60
21

A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.
George W Wright, Da Wei Huang, James D Phelan, Zana A Coulibaly, Sandrine Roulland, Ryan M Young, James Q Wang, Roland Schmitz, Ryan D Morin, Jeffrey Tang,[...]. Cancer Cell 2020
242
13

Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma.
Han W Tun, Patrick B Johnston, Lisa M DeAngelis, Pamela J Atherton, Levi D Pederson, Patricia A Koenig, Craig B Reeder, Antonio M Padula Omuro, David Schiff, Brian O'Neill,[...]. Blood 2018
47
27

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.
Jacoline E C Bromberg, Samar Issa, Katerina Bakunina, Monique C Minnema, Tatjana Seute, Marc Durian, Gavin Cull, Harry C Schouten, Wendy B C Stevens, Josee M Zijlstra,[...]. Lancet Oncol 2019
88
14

The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing.
I Vater, M Montesinos-Rongen, M Schlesner, A Haake, F Purschke, R Sprute, N Mettenmeyer, I Nazzal, I Nagel, J Gutwein,[...]. Leukemia 2015
97
12

High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites.
W Kraan, H M Horlings, M van Keimpema, E J M Schilder-Tol, M E C M Oud, C Scheepstra, P M Kluin, M J Kersten, M Spaargaren, S T Pals. Blood Cancer J 2013
131
12

Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial.
Anas Younes, Armando Santoro, Margaret Shipp, Pier Luigi Zinzani, John M Timmerman, Stephen Ansell, Philippe Armand, Michelle Fanale, Voravit Ratanatharathorn, John Kuruvilla,[...]. Lancet Oncol 2016
636
12

Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma.
Philippe Armand, Scott Rodig, Vladimir Melnichenko, Catherine Thieblemont, Kamal Bouabdallah, Gayane Tumyan, Muhit Özcan, Sergio Portino, Laura Fogliatto, Maria D Caballero,[...]. J Clin Oncol 2019
115
12

A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases.
Sophie Camilleri-Broët, Emmanuelle Crinière, Philippe Broët, Vincent Delwail, Karima Mokhtari, Anne Moreau, Michèle Kujas, Martine Raphaël, Wafae Iraqi, Catherine Sautès-Fridman,[...]. Blood 2006
256
12

Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).
James L Rubenstein, Eric D Hsi, Jeffrey L Johnson, Sin-Ho Jung, Megan O Nakashima, Barbara Grant, Bruce D Cheson, Lawrence D Kaplan. J Clin Oncol 2013
278
12

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.
Lauren E Abrey, Tracy T Batchelor, Andrés J M Ferreri, Mary Gospodarowicz, Elisa J Pulczynski, Emanuele Zucca, Justine R Smith, Agnieszka Korfel, Carole Soussain, Lisa M DeAngelis,[...]. J Clin Oncol 2005
511
11

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.
Alexander M Lesokhin, Stephen M Ansell, Philippe Armand, Emma C Scott, Ahmad Halwani, Martin Gutierrez, Michael M Millenson, Adam D Cohen, Stephen J Schuster, Daniel Lebovic,[...]. J Clin Oncol 2016
678
11

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial.
Philippe Armand, Andreas Engert, Anas Younes, Michelle Fanale, Armando Santoro, Pier Luigi Zinzani, John M Timmerman, Graham P Collins, Radhakrishnan Ramchandren, Jonathon B Cohen,[...]. J Clin Oncol 2018
362
11

PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies.
Benjamin J Chen, Bjoern Chapuy, Jing Ouyang, Heather H Sun, Margaretha G M Roemer, Mina L Xu, Hongbo Yu, Christopher D M Fletcher, Gordon J Freeman, Margaret A Shipp,[...]. Clin Cancer Res 2013
574
11

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.
Andrés J M Ferreri, Michele Reni, Marco Foppoli, Maurizio Martelli, Gerasimus A Pangalis, Maurizio Frezzato, Maria Giuseppina Cabras, Alberto Fabbri, Gaetano Corazzelli, Fiorella Ilariucci,[...]. Lancet 2009
417
11

High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma.
W Kraan, M van Keimpema, H M Horlings, E J M Schilder-Tol, M E C M Oud, L A Noorduyn, P M Kluin, M J Kersten, M Spaargaren, S T Pals. Leukemia 2014
66
15

Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy.
Michael R Green, Scott Rodig, Przemyslaw Juszczynski, Jing Ouyang, Papiya Sinha, Evan O'Donnell, Donna Neuberg, Margaret A Shipp. Clin Cancer Res 2012
468
10

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.
Robert Chen, Pier Luigi Zinzani, Michelle A Fanale, Philippe Armand, Nathalie A Johnson, Pauline Brice, John Radford, Vincent Ribrag, Daniel Molin, Theodoros P Vassilakopoulos,[...]. J Clin Oncol 2017
613
10

Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell.
M Montesinos-Rongen, A Brunn, S Bentink, K Basso, W K Lim, W Klapper, C Schaller, G Reifenberger, J Rubenstein, O D Wiestler,[...]. Leukemia 2008
109
10

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
Eckhard Thiel, Agnieszka Korfel, Peter Martus, Lothar Kanz, Frank Griesinger, Michael Rauch, Alexander Röth, Bernd Hertenstein, Theda von Toll, Thomas Hundsberger,[...]. Lancet Oncol 2010
373
10

Expression of programmed cell death 1 ligand 2 (PD-L2) is a distinguishing feature of primary mediastinal (thymic) large B-cell lymphoma and associated with PDCD1LG2 copy gain.
Min Shi, Margaretha G M Roemer, Bjoern Chapuy, Xiaoyun Liao, Heather Sun, Geraldine S Pinkus, Margaret A Shipp, Gordon J Freeman, Scott J Rodig. Am J Surg Pathol 2014
108
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.